Modular Medical, Inc. 10-Q

Item 5. Other Information None . 20 Item 6. Exhibits Exhibit Reference Filed or Furnished Number Exhibit Description Form Exhibit Filing Date Herewith 1.1 Placement Agency Agreement, dated April 19, 2026, between the Company and Maxim Group LLC 8-K 1.1 04/21/2026 3.1 Third Amended and Restated Articles of Incorporation of Modular Medical, Inc., as filed with the Secretary of State of Nevada on June 27, 2017 8-K 3.1 06/29/2017 3.2 Certificate of Amendment to the Amended and Restated Articles of Incorporation of Modular Medical, Inc., filed with the Secretary of State of the State of Nevada on November 24, 2021 8-K 3.1 12/01/2021 3.3 Certificate of Amendment to the Amended and Restated Articles of Incorporation of Modular Medical, Inc., filed with the Secretary of State of the State of Nevada on February 15, 2024 8-K 3.1 02/15/2024 3.4 Certificate of Amendment to the Amended and Restated Articles of Incorporation of Modular Medical, Inc., filed with the Secretary of State of the State of Nevada on January 23, 2026 8-K 3.1 01/23/2026 3.5 Certificate of Amendment to the Amended and Restated Articles of Incorporation of Modular Medical, Inc., filed with the Secretary of State of the State of Nevada on March 30, 2026 8-K 3.1 03/31/2026 3.6 Amended Bylaws of Modular Medical, Inc. 10-SB 3.2 03/08/2002 10.1 Sales Agreement dated April 23, 2026, between the Company and Maxim Group LLC S-3 10.1 04/23/2026 10.2 Form of Notice of Grant of Stock Option Award and Agreement pursuant to the Modular Medical, Inc. Amended and Restated 2017 Equity Incentive Plan 8-K 10.1 05/20/2026 31.1 Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 X 31.2 Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 X 32.1 Certification of Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 X 101 The following financial information from Modular Medical, Inc.’s quarterly report on Form 10-Q for the period ended June 30, 2026, filed with the SEC on August 14, 2026, formatted in Inline Extensible Business Reporting Language (Inline XBRL): (i) the Condensed Consolidated Statements of Operations for the three months ended June 30, 2026 and 2025, (ii) the Condensed Consolidated Balance Sheets as of June 30, 2026 and March 31, 2026, (iii) the Condensed Consolidated Statements of Stockholders’ Equity for the three months ended June 30, 2026 and 2025, (iv) the Condensed Consolidated Statements of Cash Flows for the three months ended June 30, 2026 and 2025, and (v) Notes to Condensed Consolidated Financial Statements. X 104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). X 21 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. MODULAR MEDICAL, INC. Date: August 14, 2026 By: /s/ James E. Besser James E. Besser Chief Executive Officer (Principal Executive Officer) By: /s/ Paul DiPerna Paul DiPerna Chairman, President, Chief Financial Officer and Treasurer (Principal Financial Officer) 22